Month: September 2020

Shenzhen, China, Sept. 25, 2020 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the second quarter ended June 30, 2020.Dr. Zhou Pengwu, the Chairman and CEO of the Company, commented, “In the second quarter, in light of the enduring adverse impact of the COVID-19 pandemic to the consumer sentiment and restrictions on general mobility in parts of China, we have been actively adjusting our business operations to adapt to the new normal. We took timely and proactive measures, including implementing control measures to limit the customer-flow and ensuring the health and safety of our customers, employees and their families even though these measures may affect our operations...

DLR Kredit har fastsat kuponrenten for perioden 1. oktober 2020 til 31. januar 2020 på følgende variabelt forrentede obligationer:ISIN-kode:   DK000634425-4              Euribor3 2028                  0,10 %ISIN-kode:   DK000634727-3              Euribor3 2029                  0,13 %Eventuelle spørgsmål kan rettes til Fondsafdelingen på tlf. 33 42 07 37.   Med venlig hilsenDLR Kredit A/SVedhæftet filRentefix20200925_EURO_DLR

Niðurstaða skuldabréfaútboðsRARIK ohf. hefur nú lokið sölu á nýjum skuldabréfaflokkum með auðkenni RARIK 011025 og RARIK 011040. Heildareftirspurn nam samtals 10.790 milljónum króna að nafnverði í báða flokka.Í skuldabréfaflokknum RARIK 011025, sem er óverðtryggður flokkur til 5 ára og fylgir 20 ára afborgunarferli, nam eftirspurn 4.220 milljónum króna að nafnverði á veginni meðalávöxtunarkröfu 3,23%. Ákveðið var að taka tilboðum að nafnverði 3.120 milljónir króna á ávöxtunarkröfunni 3,10%.Í skuldabréfaflokknum RARIK 011040, sem er verðtryggður flokkur til 20 ára, nam eftirspurn 6.570 milljónum króna að nafnverði á veginni meðalávöxtunarkröfu 0,94%. Ákveðið var að taka tilboðum að nafnverði 1.780 milljónir króna á ávöxtunarkröfunni 0,85%.Stefnt er að uppgjöri viðskipta 1. október 2020.Íslandsbanki hefur umsjón með útgáfu og útboði skuldabréfanna...

MELBOURNE, Australia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, today announces the public filing of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed public offering (the “Offering”) of American Depositary Shares (“ADSs”), each of which will represent one or a number of the Company’s ordinary shares in the United States. Concurrent with the proposed public offering, Opthea also intends to list the ADSs on the Nasdaq Global Market (“Nasdaq”).All securities to be sold in the Offering will be offered by Opthea. The number of securities to be sold and the price per ADS under any proposed Offering have not yet been determined.Opthea...

25. september 2020Announcement 308Notice to General MeetingAttachmentsAnnouncement308_Notice to General MeetingRemumeration policy Rovsing_finalROVSING Annual Report 2019-2020_final

Press releaseShare-based incentive schemeThe share-based incentive scheme resolved by the 2020 Annual General Meeting where around 20 members of senior management were offered to acquire up to 244,000 call options on repurchased class B shares has been fully subscribed.The call options will be transferred at a price of SEK 4.96 per call option, equivalent to the market value according to an external independent valuation, applying the Black-Scholes-model. The redemption price of the call options amounts to SEK 99.50, equivalent to 120 percent of the volume-weighted average of the paid market price for the shares during the period from 27 August to 9 September 2020, inclusive. Each call option entitles the holder to acquire one repurchased class B share during the period from 11 September 2023 to 7 June 2024, inclusive.Stockholm, 25 September...

PressmeddelandeAktierelaterat incitamentsprogramDet av årsstämman 2020 beslutade aktierelaterade incitamentsprogrammet som omfattar cirka 20 ledningspersoner om maximalt 244 000 köpoptioner på återköpta aktier av serie B har fulltecknats.Köpoptionerna kommer att överlåtas till ett pris av 4,96 SEK per köpoption vilket motsvarar marknadsvärdet enligt en extern oberoende värdering utförd i enlighet med Black-Scholes-modellen. Lösenkursen för köpoptionerna uppgår till 99,50 SEK motsvarande 120 procent av den genomsnittliga aktiekursen under mätperioden 27 augusti – 9 september 2020. Varje köpoption berättigar till förvärv av en återköpt aktie av serie B under perioden från och med den 11 september 2023 till och med den 7 juni 2024.Stockholm den 25 september 2020Bergman & Beving AB (publ)För ytterligare information kontakta:Peter Schön,...

The treasury bills for sale have the following stock exchange codes:        The sale will settle on 1 October 2020 at the stop-rate for each serie. In case of bid on stop-rate a pro-rata ratio may occur.The deadline for bidding is 10.15 on the day of the auction.

De udbudte beviser har følgende fondskoder:Salget vil blive afregnet den 1. oktober 2020 til skæringsrenten for hver serie. For bud på skæringsrenten kan der blive tale om pro rata tildeling.Sidste frist for bud er kl. 10.15 på auktionsdagen.

In accordance with a resolution for the Nominating Committee made by the 2011 Annual General Meeting, and which applies until further notice, the Chairman of the Board is assigned the task of contacting four shareholders from among the largest registered shareholders in terms of votes in Euroclear Sweden AB’s printout of the shareholder register as per the last business day in August, who each appoints one representative who is not a director on the Company’s board, to form together with the Chairman of the Board a Nominating Committee for the time until a new Nominating Committee has been appointed. The Nominating Committee appoints a committee chair from among its members. The composition of the Nominating Committee shall be made public not later than six months before the next Annual General Meeting. No fee is payable for...